Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[W]hat the Switzerland negotiations ultimately lead to may help determine who the next U.S. president will be, as much as they will define the rules of the game in the Middle East.